BriefCase vs University of Birmingham

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

BriefCase

by Aidoc Medical

University of Birmingham

by University of Birmingham

AI Verdict

BriefCase is an FDA-cleared AI solution focused on streamlining communication and collaboration for critical medical imaging findings, primarily for radiology triage and notification. AI Consult, developed by the University of Birmingham, is a large language model-based clinical decision support tool embedded in EMRs, providing real-time diagnostic and treatment suggestions across broader medical specialties. While both aim to enhance clinical decision-making with AI, BriefCase specializes in imaging workflow and communication, whereas AI Consult offers general diagnostic and treatment support.

Choose BriefCase if…

Choose BriefCase if your large hospital or health system needs an FDA-cleared, AI-powered solution to rapidly identify and communicate critical medical imaging findings across care teams. It excels at streamlining workflows for urgent cases like intracranial hemorrhages or pulmonary embolisms, ensuring timely alerts and collaboration among specialists.

View BriefCase →

Choose University of Birmingham if…

Choose University of Birmingham's AI Consult if you are a healthcare institution or researcher interested in exploring and integrating a large language model-based clinical decision support tool directly within an electronic medical record system. This tool is ideal for real-time diagnostic and treatment suggestions, particularly in academic or research-focused settings aiming to leverage advanced AI for internal medicine, family medicine, and hospital medicine.

View University of Birmingham →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	BriefCase	University of Birmingham
Pricing	Enterprise	N/a
Deployment	Cloud	N/A
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	N/a
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

BriefCase

BriefCase offers a mobile app for care team collaboration and integrates seamlessly with existing PACS, RIS, and EHR systems, suggesting a well-developed and accessible user experience. In contrast, AI Consult's deployment and mobile app availability are not specified, making its usability less clear. The University of Birmingham does offer an MSc in User Experience Design, indicating an understanding of UX principles, but this doesn't directly translate to the usability of AI Consult.

Clinical Value

BriefCase

BriefCase is an FDA-cleared solution with multiple indications, supported by over 230 published studies or abstracts demonstrating its reliability and validity in detecting critical findings and improving turnaround times. AI Consult, while shown to improve clinical decision-making in a large real-world trial, did not significantly change short-term patient outcomes and lacks specific FDA clearance.

Pricing & Value

Tie

BriefCase operates on an enterprise pricing model, which, while offering customizability, lacks transparency with a baseline starting around $50,000 per site per year. AI Consult, being a university-developed tool, does not have a product-based pricing structure, making a direct comparison of value difficult. Neither tool offers transparent, readily available pricing for direct comparison.

Enterprise Readiness

BriefCase

BriefCase is designed for large hospitals and health systems, boasts over 500 global customers, and is HIPAA, SOC2, and GDPR compliant, indicating strong enterprise readiness. It also offers API availability and cloud deployment. AI Consult, developed by a university, lacks specified deployment, API availability, or customer count, suggesting it is not yet scaled for broad enterprise adoption.

Innovation

BriefCase

BriefCase leverages AI-driven critical finding detection and offers advanced features like automated follow-up tracking and customizable communication protocols, demonstrating innovative application of AI in radiology workflow. Aidoc also emphasizes transparency in its AI models through model cards, aligning with emerging industry standards. While AI Consult uses a large language model for real-time diagnostic and treatment suggestions, its features, as described, are more foundational to AI in clinical decision support.

Support & Docs

BriefCase

BriefCase, as a commercial product from Aidoc, is expected to have comprehensive support and documentation, including user guides and customer success resources, given its large customer base and enterprise focus. The University of Birmingham, while providing guidance on AI tool usage for its students and staff, does not offer product-specific support or documentation for AI Consult in a commercial sense.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	BriefCase	University of Birmingham
Name	BriefCase	AI Consult
Company	Aidoc Medical	University of Birmingham
Description	FDA-cleared AI-powered communication and collaboration solution integrated into the Aidoc platform, designed to streamline the sharing of critical medical imaging findings among care teams.	A large language model-based clinical decision support tool embedded within an electronic medical record system, providing real-time diagnostic and treatment suggestions.
Mobile App	both	N/A
API Available	yes	N/A
Key Features	AI-driven critical finding detection (via Aidoc platform), Secure, real-time communication of findings, Customizable communication protocols, Automated follow-up tracking and reminders, Seamless integration with PACS, RIS, and EHR systems, Comprehensive audit trails for all communications, Prioritization of urgent cases for immediate attention, Mobile access for care team collaboration	Large language model-based, Clinical decision support, Real-time suggestions, Embedded within EMR, Diagnostic assistance, Treatment suggestions

Videos

Demos, reviews, and walkthroughs featuring BriefCase and University of Birmingham.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows and EHR systems?

BriefCase is designed for seamless integration with PACS, RIS, and EHR systems, providing AI-driven critical finding detection and communication within the existing radiology workflow. AI Consult, on the other hand, is embedded directly within the electronic medical record system, providing real-time diagnostic and treatment suggestions as clinicians enter information.

What is the accuracy and sensitivity of each tool in detecting relevant clinical conditions?

BriefCase has demonstrated high accuracy in detecting various conditions. For instance, in a pivotal study for intra-abdominal free gas (IFG) triage, it achieved 94.2% sensitivity and 94.6% specificity. For 11 newly cleared indications, Aidoc's foundation model achieved a mean sensitivity of 97% and a mean specificity of 98%. AI Consult has been shown to improve the quality of clinical decision-making and diagnostic accuracy, with one study reporting a 100% sensitivity for detecting melanoma and 99.5% for all skin cancers.

For which medical specialties are these tools most suitable?

BriefCase is primarily suited for specialties involved in medical imaging, such as Cardiology, Emergency Medicine, Neurology, Pulmonology, and Radiology, by flagging critical findings in CT scans across various body regions. AI Consult is designed for broader clinical decision support within Family Medicine, Hospital Medicine, and Internal Medicine, offering real-time diagnostic and treatment suggestions embedded in the EMR.

What is the typical learning curve for physicians to effectively use each tool?

BriefCase operates in parallel to the standard of care, providing notifications and low-quality preview images for triage purposes, suggesting a relatively low learning curve for radiologists to incorporate the alerts into their existing workflow. AI Consult functions in the background, analyzing information and generating suggestions within the EMR, aiming to integrate smoothly without undermining clinician autonomy, implying a focus on ease of use within familiar EMR interfaces.

What audit-trail features are available to track the AI's input and physician's decisions?

BriefCase offers comprehensive audit trails for all communications, allowing for tracking of the AI's critical finding detections and the subsequent sharing of these findings among care teams. AI Consult, being embedded in the EMR and providing real-time suggestions, would likely leverage the EMR's existing audit capabilities to track the AI's input and how it informs physician decisions, though specific features are not detailed.

What are the considerations for rolling out these tools across multiple hospital sites or a large health system?

BriefCase is designed for large hospitals and health systems, with its AI operating system (aiOS) sustaining performance at a foundation-model scale through data normalization, continuous monitoring, and built-in governance, enabling multi-condition clinical AI deployment without re-architecting infrastructure. AI Consult's deployment across multiple primary care clinics in a real-world trial suggests scalability, and the University of Birmingham's focus on data standards and reducing bias in AI health tech indicates considerations for diverse populations and settings in multi-site rollouts.

How do these tools contribute to clinical decision-making beyond basic alerts?

BriefCase assists in workflow triage by flagging suspected critical findings, enabling prioritization of urgent cases and potentially reducing turnaround times for reports. It also supports care coordination through mobile alerts and integration with patient management solutions, including displaying RV/LV ratios and relevant labs for PE cases. AI Consult provides real-time diagnostic and treatment suggestions, acting as a clinical decision support tool that can improve the quality of clinical documentation and treatment planning, and potentially lead to more cost-conscious prescribing choices.